FILTER RECORDS BY
PERIOD
<18th Century
18th Century
19th Century
1900-1949
1950-1999
21st Century
ORIGIN OF AUTHOR
American
Arab (medieval)
Australian
Austrian
Belgian
British
Canadian
Chinese
Chinese (medieval)
Colombian
Croatian
Czech
Danish
Dutch
Egyptian
Egyptian (ancient)
English (medieval)
Finnish
Flemish
French
German
Greek
Greek (ancient)
Hebrew (ancient)
Hungarian
Indian
Indonesian
Irish
Israeli
Italian
Italian (medieval)
Japanese
Multinational
Norwegian
Persian (medieval)
Polish
Portuguese
Roman (ancient)
Russian
South African
Spanish
Swedish
Swiss
Unknown
Vietnamese
Glasziou P, Jones M, Clarke M (2024) Setting new research in the context of previous research: some options. BMJ Evidence Based Medicine. 29(1):44-46 View
Andreasen J, Nørgaard B, Juhl CB, Yost J, Brunnhuber K, Robinson KA, Lund H (2022) Systematic reviews are rarely used to contextualise new results-a systematic review and meta-analysis of meta-research studies. Systematic Reviews 11(1) 189. View
Pérez-Gaxiola G, Verdugo-Paiva F, Rada G, Flórez ID (2021) Assessment of Duplicate Evidence in Systematic Reviews of Imaging Findings of Children With COVID-19. JAMA Network Open 4(1):e2032690. View
McLennan S, Nussbaumer-Streit B, Hemkens LG, Briel M (2021) Barriers and Facilitating Factors for Conducting Systematic Evidence Assessments in Academic Clinical Trials. JAMA Network Open. 4(11):e2136577. url: doi/org/10.1001/jamanetworkopen.2021.36577 View
RECOVERY Trial Team (2020) Randomized Evaluation of COVID019 Therapy (RECOVERY). RECOVERY Central Coordinating Office, Oxford. www.recoverytrial.net View
Horby P, Mafham M, Linsell L, Bell JL, Staplin N, Emberson JR, Wiselka M, Ustianowski A, Elmahi E, Prudon B, Whitehouse A, Felton T, Williams J, Faccenda J, Underwood J, Baillie JK, Chappell L, Faust SN, Jaki T, Jeffery K, Lim WS, Montgomery A, Rowan K, Tarning J, Watson JA, White NJ, Juszczak E, Haynes R, Landray MJ (2020) Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial. doi: https://doi.org/10.1101/2020.07.15.20151852 View
Horby P, Lim WS, Emberson J, Mafham M, Bell J, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffrey K, Montgomery A, Rowan K, Juszcak E, Baillie JK, Haynes R, Landray MJ, on behalf of the RECOVERY Collaborative Group (2020) Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report. medRχiv. Doi: https://doi.org/10.1101/2020.06.22.20137273 View
Pan H, Peto R, Karim QA, Alejandria M, Henao-Restrepo AM, García CH, Kieny MP, Malekzadeh R, Murthy S, Preziosi MP, Reddy S, Periago MR, Sathiyamoorthy V, Røttingen JA, Swaminathan S, WHO Solidarity trial consortium (2020) Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results. MedRxiv. doi: https://doi.org/10.1101/2020.10.15.20209817 View
Bradley SH, DeVito NJ, Lloyd KE, Richards GC, Rombey T, Wayant C, Gill PJ (2020) Reducing bias and improving transparency in medical research: a critical overview of the problems, progress and suggested next steps. Journal of the Royal Society of Medicine 113:433-443. View
Ritskes-Hoitinga M, Leenaars C, Beumer W, Roo TC, Stafleu F, Meijboom FLB (2020) Improving Translation by Identifying Evidence for More Human-Relevant Preclinical Strategies. Animals 10, 1170; doi:10.3390/ani10071170 View
Ritskes-Hoitinga M, Wever K (2018) Improving the conduct, reporting, and appraisal of animal research. BMJ 360:j4935 doi: 10.1136/bmj.j4935. View
Pound P, Ritskes‑Hoitinga M (2018) Is it possible to overcome issues of external validity in preclinical animal research? Why most animal models are bound to fail. J Transl Med 16:304 https://doi.org/10.1186/s12967-018-1678-1. View
Altman DG (2015) Making research articles fit for purpose: structured reporting of key methods and findings. Trials 16:53. View
Abraha I, Cherubini A, Cozzolino F, De Florio R, Luchetta ML, Rimland JM, Folletti I, Marchesi M, Germani A, Orso M, Eusebi P, Montedori A (2015) Deviation from intention to treat analysis in randomised trials and treatment effect estimates: meta-epidemiological study. BMJ 2015;350:h2445. View
Bafeta A, Trinquart L, Seror R, Ravaud P (2014) Reporting of results from network meta-analyses: methodological systematic review. BMJ 348:g1741 View
Pound P, Bracken M (2014) Is animal research sufficiently evidence based to be a cornerstone of biomedical research? BMJ 348:g3387 doi: 10.1136/bmj.g3387. View
Clarke M, Hopewell S (2013) Many reports of randomised trials still don’t begin or end with a systematic review of the relevant evidence. Journal of the Bahrain Medical Society 24: 145-8. View
White IR, Carpenter J, Horton NJ (2012) Including all individuals is not enough: lessons for intention-to-treat analysis. Clinical Trials 9:396-407. View
Robinson KA, Goodman SN (2011) A systematic examination of the citation of prior research in reports of randomized, controlled trials. Annals of Internal Medicine 154(1): 50-55. View
Montedori A, Cherubini A, Bonacini MI, Casazza G, Luchetta ML, Duca P, Cozzolino F, Abraha I (2011) Modified versus standard intention-to-treat reporting: Are there differences in methodological quality, sponsorship, and findings in randomised trials? A cross-sectional study. Trials 12:58. View
Clarke M, Hopewell S, Chalmers I (2010) Clinical trials should begin and end with systematic reviews of relevant evidence: 12 years and waiting. Lancet 376: 20-1. View
Clarke M, Hopewell S, Chalmers I (2007) Reports of clinical trials should begin and end with up-to-date systematic reviews of other relevant evidence: a status report. Journal of the Royal Society of Medicine 100: 187-90. View
Clarke L, Clarke M, Clarke T (2007) How useful are Cochrane reviews in identifying research needs? Journal of Health Services Research and Policy 12, 101-103. journals.sagepub.com/doi/10.1258/135581907780279648 View
Atkins D, Eccles M, Flottorp S, Guyatt GH, Henry D, Hill S, Liberati A, O'Connell D, Oxman AD, Phillips B, Schünemann H, Edejer TT, Vist GE, Williams JW and The GRADE Working Group (2004) Systems for grading the quality of evidence and the strength of recommendations I: Critical appraisal of existing approaches The GRADE Working Group. BMC Health Services Research 2004 4:38 doi.org/10.1186/1472-6963-4-38. View
Hopewell S, Clarke M (2003) How important is the size of a reprint order? International Journal of Technology Assessment in Health Care 19:711-714. View
Clarke M, Alderson P, Chalmers I (2002) Discussion sections in reports of controlled trials published in general medical journals. JAMA 287: 2799-801. View
Ruiz-Canela M, Martinez-Gonzalez MA, de Irala-Estevez J (2000) Intention-to-treat analysis is related to methodological quality. BMJ 320:107-108. View
Hollis S, Campbell F (1999) What is meant by intention-to-treat analysis? Survey of published randomised controlled trials. BMJ 319:670-674. View
Jefferson T, Deeks J (1999) The use of systematic reviews for editorial peer reviewing: a population approach. . In: Godlee F, Jefferson T, eds. Peer review in health sciences. London: BMJ Books, pp 224-234. View
Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, Tugwell P, Klassen TP (1998) Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 352:609-613. View
The CONSORT Group (1996) Improving the quality of reporting of randomized controlled trials. The CONSORT Statement. JAMA 276:637-639. View
Moher D, Jadad AR, Nichol G, Penman M, Tugwell P, Walsh S (1995) Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Control Clinical Trials 16:62-73. View
Schulz KF, Chalmers I, Altman DG, Grimes DA, Doré CJ (1995) The methodologic quality of randomization as assessed from reports of trials in specialist and general medical journals. Online Journal of Current Clinical Trials 4:197. View
Standards of Reporting Trials Group (1994) A proposal for structured reporting of randomized controlled trials. JAMA 272:1926-31. View
Moher D, Dulberg CS, Wells GA. (1994) Statistical power, sample size, and their reporting in randomized controlled trials. JAMA 272:122-4. View
Oxman AD, Guyatt GH, Cook DJ, Jaeschke R, Heddle N, Keller J (1993) An index of scientific quality for health reports in the lay press. Journal of Clinical Epidemiology 46:987-1001. View
Hill AB, Hill ID (1991) Differential exclusions. In: Bradford Hill’s Principles of Medical Statistics. 12th edition. London: Edward Arnold. pp 226-228. View
Oxman AD, Guyatt GH (1991) Validation of an index of the quality of review articles. Journal of Clinical Epidemiology 44:121-1278. View
Guyatt GH (1991) Evidence-Based Medicine. American College of Physicians Journal Club March/April: A-16. View
Haynes RB, Mulrow CD, Huth EJ, Altman DG, Gardner MJ (1990) More informative abstracts revisited. Annals of Internal Medicine 113:69-75. View
Huth EJ (1987) Structured abstracts for papers reporting clinical trials. Annals of Internal Medicine 106:626-627. View
Pocock SJ, Hughes MD, Lee RJ (1987) Statistical problems in the reporting of clinical trials. A survey of three medical journals. New England Journal of Medicine 317:426-32. View
Roifman CM, Levison H, Gelfand EW (1987) High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease. Lancet 329: 1075–1077. View
Ad Hoc Working Group for Critical Appraisal of the Medical Literature (1987) A proposal for more informative abstracts of clinical articles. Annals of Internal Medicine 106:598-604. View
Altman DG, Gore SM, Gardner MJ, Pocock SJ (1983) Statistical guidelines for contributors to medical journals. BMJ 286:1489-93. View
Hemminki E (1982) Quality of clinical trials – a concern of three decades. Methods of Information in Medicine 21:81-85. View
Altman DG (1982) Statistics in medical journals. Statistics in Medicine 1:59-71. View
Hemminki E (1981) Quality of reports of clinical trials submitted by the drug industry to the Finnish and Swedish control authorities. European Journal of Clincal Pharmacology 19:157-165. View
Chalmers TC, Smith JH, Blackburn B, Silverman B, Schroeder B, Reitman D, Ambroz A (1981) A method for assessing the quality of a randomized control trial. Controlled Clinical Trials 2: 31-49. View
Hampton JR (1981) Presentation and analysis of the results of clinical trials in cardiovascular disease BMJ 282:1371-1373. View
Altman DG (1981) Statistics and ethics in medical research. VIII-Improving the quality of statistics in medical journals. BMJ 282:44–47. View
Ertl N (1969) A new way of documenting scientific data from medical publications. Karger Gazette 20:1-4. View
Hill AB (1965) The reasons for writing. BMJ 2:870. View
Mahon WA, Daniel EE (1964) A method for the assessment of reports of drug trials. Canadian Medical Association Journal 90:565-9. View
Glick BS (1963) Inadequacies in the reporting of clinical drug research. Psychiatr Q 37:234-44. View
Glick BS, Margolis R (1962) A study of the influence of experimental design on clinical outcome in drug research. American Journal of Psychiatry 118:1087-1096. View
Bywaters E (1960) Rheumatoid arthritis. Treatment and illustrative answers. In: Hill AB ed. Controlled Clinical Trials. Oxford: Blackwell Scientific Publications, pp 75-83. View
Knowelden J (1960) The analysis and presentation of results. In: Hill AB, ed. Controlled Clinical Trials. In: Hill AB, ed. Controlled Clinical Trials. Oxford: Blackwell Scientific Publications, 155-159. View
Waife SO (1959) Problems of publication. In: Waife SO, Shapiro AP (1959). The clinical evaluation of new drugs. New York: Hoeber-Harper, 213-216. View
Knowelden J (1959) Prophylactic trials. In: Witts LJ ed. Medical Surveys and Clinical Trials. London: Oxford University Press. pp 118-133. View
Laurence DR, ed. (1959) Quantitative Methods in Human Pharmacology and Therapeutics. London: Pergamon Press. View
Lasagna L, Meier P (1959) Experimental Design and Statistical Problems. In: Waife SO, Shapiro AP, eds. The Clinical Evaluation of New Drugs. New York: Hoeber. pp 37-60. View
Sutherland I (1958) Statistical aspects of clinical trials. In: Dodds C, ed. Report of a Symposium on Clinical Trials held at The Royal Society of Medicine, London, 25 April, p 53, pp 50-55. View
Cole JO, Ross S, Bouthilet L, Freeman H, Bennett IF, Hoffman JL, Lehmann H (1957) Recommendations for reporting studies of psychiatric drugs. Public Health Report 72:638–645. View
Herdan G (1955) Statistics of Therapeutic Trials. Amsterdam: Elsevier. View
Mainland D (1952) Intercurrent Events. In: Elementary Medical Statistics: the principles of quantitative medicine. London: WB Saunders Company, p 109. [Facimile copy printed and bound in India. Pranava Books. 2- LB100151138852 -301 -4 sa.] View
Daniels M (1951) Clinical evaluation of chemotherapy in tuberculosis. British Medical Bulletin 7:320-326. View
Daniels M (1950) Scientific appraisement of new drugs in tuberculosis. American Review of Tuberculosis 61:751-756. View
Mainland D (1938) The treatment of clinical and laboratory data: an introduction to statistical ideas and methods for medical and dental workers. Edinburgh: Oliver and Boyd. View
Wistar Institute (1934) Style brief, a guide for authors in preparing manuscripts and drawings for the most effective and economical method of publishing biological research. Philadelphia: The Wistar Institute Press. View
Codman EA (1916) A study in hospital efficiency. Boston: privately printed. View
Show
ALL ARTICLES
Brief histories
Commentaries
Biographies
Personal reflections
Doctoral theses
Chalmers I, Matthews R, Glasziou P, Boutron I, Armitage P† (2023).Analysis of clinical trial by Treatment Allocated or by Treatment Received? Applying ‘the intention-to-treat principle’. JLL Bulletin: Commentaries on the history of treatment evaluation. View
Schulz KF, Chalmers I, Altman DG†, Grimes DA, Moher D, Hayes RJ (2018).‘Allocation concealment’: the evolution and adoption of a methodological term. JLL Bulletin: Commentaries on the history of treatment evaluation. View
Altman DG† (2017).Donald Mainland: anatomist, educator, thinker, medical statistician, trialist, rheumatologist. JLL Bulletin: Commentaries on the history of treatment evaluation. View
Haynes RB (2016).Improving reports of research by more informative abstracts: a personal reflection JLL Bulletin: Commentaries on the history of treatment evaluation. View
Donaldson IML (2016).Reflections on translating passages on ‘empirical’ and ‘dogmatic’ medicine in Celsus’s De medicina. JLL Bulletin: Commentaries on the history of treatment evaluation. View
Altman DG†, Simera I (2015).A history of the evolution of guidelines for reporting medical research: the long road to the EQUATOR Network. JLL Bulletin: Commentaries on the history of treatment evaluation. View
Wager E (2015).Good Publication Practice 3: reflections on becoming a guideline grandmother. JLL Bulletin: Commentaries on the history of treatment evaluation. View
Crofton J† (2005).Marc Daniels (1907-1953), a pioneer in establishing standards for clinical trial methods and reporting. JLL Bulletin: Commentaries on the history of treatment evaluation. View
Nothing found, please try resetting your search filters